ACADIA Pharmaceuticals Inc (NAS:ACAD)
$ 16.95 -0.42 (-2.42%) Market Cap: 2.89 Bil Enterprise Value: 2.37 Bil PE Ratio: 22.27 PB Ratio: 5.01 GF Score: 75/100

ACADIA Pharmaceuticals Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 02, 2021 / 05:30PM GMT
Release Date Price: $22.62 (+1.21%)
Christopher Lawrence Howerton
Jefferies LLC, Research Division - Equity Analyst

Hey, everybody. Thank you so much for joining us. My name is Chris Howerton, part of the Research -- Biotechnology Research team here at Jefferies. And I'm very pleased to be hosting a chat here with ACADIA. And on behalf of the management team, we have Steve, Elena and Serge. So thanks so much for joining us, everybody.

Stephen R. Davis
ACADIA Pharmaceuticals Inc. - CEO & Director

Thank you, Chris.

Christopher Lawrence Howerton
Jefferies LLC, Research Division - Equity Analyst

All right. So I guess, maybe before we get into a chat, Steve, would you mind just kind of maybe giving us a high-level overview of where you're at or maybe an elevator pitch?

Stephen R. Davis
ACADIA Pharmaceuticals Inc. - CEO & Director

Yes. Yes. Thanks much, Chris. So I'll just try to do a little bit of brief level setting and then we'll get right to the Q&A.

So I'll just start by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot